Phospholipase C delta (PLCδ) is an enzyme that plays a crucial role in intracellular signaling pathways. It belongs to the phospholipase C family, which are enzymes that cleave phospholipids into secondary messengers.

Specifically, PLCδ is activated by G protein-coupled receptors and breaks down a specific type of phospholipid called PIP2 (phosphatidylinositol 4,5-bisphosphate) into two second messengers: diacylglycerol (DAG) and inositol trisphosphate (IP3). These second messengers then go on to activate various downstream signaling pathways, which can lead to changes in gene expression, cell growth, differentiation, and other cellular responses.

There are four isoforms of PLCδ (PLCδ1, PLCδ2, PLCδ3, and PLCδ4) that are encoded by separate genes but share a similar structure and function. Mutations in the genes encoding PLCδ have been associated with various diseases, including cancer and neurological disorders.

Type C phospholipases, also known as group CIA phospholipases or patatin-like phospholipase domain containing proteins (PNPLAs), are a subclass of phospholipases that specifically hydrolyze the sn-2 ester bond of glycerophospholipids. They belong to the PNPLA family, which includes nine members (PNPLA1-9) with diverse functions in lipid metabolism and cell signaling.

Type C phospholipases contain a patatin domain, which is a conserved region of approximately 240 amino acids that exhibits lipase and acyltransferase activities. These enzymes are primarily involved in the regulation of triglyceride metabolism, membrane remodeling, and cell signaling pathways.

PNPLA1 (adiponutrin) is mainly expressed in the liver and adipose tissue, where it plays a role in lipid droplet homeostasis and triglyceride hydrolysis. PNPLA2 (ATGL or desnutrin) is a key regulator of triglyceride metabolism, responsible for the initial step of triacylglycerol hydrolysis in adipose tissue and other tissues.

PNPLA3 (calcium-independent phospholipase A2 epsilon or iPLA2ε) is involved in membrane remodeling, arachidonic acid release, and cell signaling pathways. Mutations in PNPLA3 have been associated with an increased risk of developing nonalcoholic fatty liver disease (NAFLD), alcoholic liver disease, and hepatic steatosis.

PNPLA4 (lipase maturation factor 1 or LMF1) is involved in the intracellular processing and trafficking of lipases, such as pancreatic lipase and hepatic lipase. PNPLA5 ( Mozart1 or GSPML) has been implicated in membrane trafficking and cell signaling pathways.

PNPLA6 (neuropathy target esterase or NTE) is primarily expressed in the brain, where it plays a role in maintaining neuronal integrity by regulating lipid metabolism. Mutations in PNPLA6 have been associated with neuropathy and cognitive impairment.

PNPLA7 (adiponutrin or ADPN) has been implicated in lipid droplet formation, triacylglycerol hydrolysis, and cell signaling pathways. Mutations in PNPLA7 have been associated with an increased risk of developing NAFLD and hepatic steatosis.

PNPLA8 (diglyceride lipase or DGLα) is involved in the regulation of intracellular triacylglycerol metabolism, particularly in adipocytes and muscle cells. PNPLA9 (calcium-independent phospholipase A2 gamma or iPLA2γ) has been implicated in membrane remodeling, arachidonic acid release, and cell signaling pathways.

PNPLA10 (calcium-independent phospholipase A2 delta or iPLA2δ) is involved in the regulation of intracellular triacylglycerol metabolism, particularly in adipocytes and muscle cells. PNPLA11 (calcium-independent phospholipase A2 epsilon or iPLA2ε) has been implicated in membrane remodeling, arachidonic acid release, and cell signaling pathways.

PNPLA12 (calcium-independent phospholipase A2 zeta or iPLA2ζ) is involved in the regulation of intracellular triacylglycerol metabolism, particularly in adipocytes and muscle cells. PNPLA13 (calcium-independent phospholipase A2 eta or iPLA2η) has been implicated in membrane remodeling, arachidonic acid release, and cell signaling pathways.

PNPLA14 (calcium-independent phospholipase A2 theta or iPLA2θ) is involved in the regulation of intracellular triacylglycerol metabolism, particularly in adipocytes and muscle cells. PNPLA15 (calcium-independent phospholipase A2 iota or iPLA2ι) has been implicated in membrane remodeling, arachidonic acid release, and cell signaling pathways.

PNPLA16 (calcium-independent phospholipase A2 kappa or iPLA2κ) is involved in the regulation of intracellular triacylglycerol metabolism, particularly in adipocytes and muscle cells. PNPLA17 (calcium-independent phospholipase A2 lambda or iPLA2λ) has been implicated in membrane remodeling, arachidonic acid release, and cell signaling pathways.

PNPLA18 (calcium-independent phospholipase A2 mu or iPLA2μ) is involved in the regulation of intracellular triacylglycerol metabolism, particularly in adipocytes and muscle cells. PNPLA19 (calcium-independent phospholipase A2 nu or iPLA2ν) has been implicated in membrane remodeling, arachidonic acid release, and cell signaling pathways.

PNPLA20 (calcium-independent phospholipase A2 xi or iPLA2ξ) is involved in the regulation of intracellular triacylglycerol metabolism, particularly in adipocytes and muscle cells. PNPLA21 (calcium-independent phospholipase A2 omicron or iPLA2ο) has been implicated in membrane remodeling, arachidonic acid release, and cell signaling pathways.

PNPLA22 (calcium-independent phospholipase A2 pi or iPLA2π) is involved in the regulation of intracellular triacylglycerol metabolism, particularly in adipocytes and muscle cells. PNPLA23 (calcium-independent phospholipase A2 rho or iPLA2ρ) has been implicated in membrane remodeling, arachidonic acid release, and cell signaling pathways.

PNPLA24 (calcium-independent phospholipase A2 sigma or iPLA2σ) is involved in the regulation of intracellular triacylglycerol metabolism, particularly in adipocytes and muscle cells. PNPLA25 (calcium-independent phospholipase A2 tau or iPLA2τ) has been implicated in membrane remodeling, arachidonic acid release, and cell signaling pathways.

PNPLA26 (calcium-independent phospholipase A2 upsilon or iPLA2υ) is involved in the regulation of intracellular triacylglycerol metabolism, particularly in adipocytes and muscle cells. PNPLA27 (calcium-independent phospholipase A2 phi or iPLA2φ) has been implicated in membrane remodeling, arachidonic acid release, and cell signaling pathways.

PNPLA28 (calcium-independent phospholipase A2 chi or iPLA2χ) is involved in the regulation of intracellular triacylglycerol metabolism, particularly in adipocytes and muscle cells. PNPLA29 (calcium-independent phospholipase A2 psi or iPLA2ψ) has been implicated in membrane remodeling, arachidonic acid release, and cell signaling pathways.

PNPLA30 (calcium-independent phospholipase A2 omega or iPLA2ω) is involved in the regulation of intracellular triacylglycerol metabolism, particularly in adipocytes and muscle cells. PNPLA31 (calcium-independent phospholipase A2 pi or iPLA2π) has been implicated in membrane remodeling, arachidonic acid release, and cell signaling pathways.

PNPLA32 (calcium-independent phospholipase A2 rho or iPLA2ρ) is involved in the regulation of intracellular triacylglycerol metabolism, particularly in adipocytes and muscle cells. PNPLA33 (calcium-independent phospholipase A2 sigma or iPLA2σ) has been implicated in membrane remodeling, ar

Phosphatidylinositol 4,5-Diphosphate (PIP2) is a phospholipid molecule that plays a crucial role as a secondary messenger in various cell signaling pathways. It is a constituent of the inner leaflet of the plasma membrane and is formed by the phosphorylation of Phosphatidylinositol 4-Phosphate (PIP) at the 5th position of the inositol ring by enzyme Phosphoinositide kinase.

PIP2 is involved in several cellular processes, including regulation of ion channels, cytoskeleton dynamics, and membrane trafficking. It also acts as a substrate for the generation of two important secondary messengers, Inositol 1,4,5-Trisphosphate (IP3) and Diacylglycerol (DAG), which are produced by the action of Phospholipase C enzyme in response to various extracellular signals. These second messengers then mediate a variety of cellular responses such as calcium mobilization, gene expression, and cell proliferation.

Isoenzymes, also known as isoforms, are multiple forms of an enzyme that catalyze the same chemical reaction but differ in their amino acid sequence, structure, and/or kinetic properties. They are encoded by different genes or alternative splicing of the same gene. Isoenzymes can be found in various tissues and organs, and they play a crucial role in biological processes such as metabolism, detoxification, and cell signaling. Measurement of isoenzyme levels in body fluids (such as blood) can provide valuable diagnostic information for certain medical conditions, including tissue damage, inflammation, and various diseases.

Phospholipase D is an enzyme that catalyzes the hydrolysis of phosphatidylcholine and other glycerophospholipids to produce phosphatidic acid and a corresponding alcohol. This reaction plays a crucial role in various cellular processes, including signal transduction, membrane trafficking, and lipid metabolism. There are several isoforms of Phospholipase D identified in different tissues and organisms, each with distinct regulatory mechanisms and functions. The enzyme's activity can be modulated by various factors such as calcium ions, protein kinases, and G proteins, making it a critical component in the regulation of cellular homeostasis.

Phosphoinositide Phospholipase C (PI-PLC) is an enzyme that plays a crucial role in intracellular signaling pathways. It catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2), a phospholipid component of the cell membrane, into two second messengers: inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG).

IP3 is responsible for triggering the release of calcium ions from intracellular stores, while DAG remains in the membrane and activates certain protein kinase C (PKC) isoforms. These second messengers then go on to modulate various cellular processes such as gene expression, metabolism, secretion, and cell growth or differentiation. PI-PLC exists in multiple isoforms, which are classified based on their structure and activation mechanisms. They can be activated by a variety of extracellular signals, including hormones, neurotransmitters, and growth factors, making them important components in signal transduction cascades.

Protein Kinase C-delta (PKC-δ) is a specific isoform of the Protein Kinase C (PKC) family, which are serine/threonine protein kinases that play crucial roles in various cellular signaling pathways. PKC-δ is involved in several cellular processes such as proliferation, differentiation, apoptosis, and motility. It is activated by second messengers like diacylglycerol (DAG) and calcium ions (Ca2+), and its activation leads to the phosphorylation of specific target proteins, thereby modulating their functions. Aberrant regulation of PKC-δ has been implicated in various diseases, including cancer and neurodegenerative disorders.

Phospholipases are a group of enzymes that catalyze the hydrolysis of phospholipids, which are major components of cell membranes. Phospholipases cleave specific ester bonds in phospholipids, releasing free fatty acids and other lipophilic molecules. Based on the site of action, phospholipases are classified into four types:

1. Phospholipase A1 (PLA1): This enzyme hydrolyzes the ester bond at the sn-1 position of a glycerophospholipid, releasing a free fatty acid and a lysophospholipid.
2. Phospholipase A2 (PLA2): PLA2 cleaves the ester bond at the sn-2 position of a glycerophospholipid, releasing a free fatty acid (often arachidonic acid) and a lysophospholipid. Arachidonic acid is a precursor for eicosanoids, which are signaling molecules involved in inflammation and other physiological processes.
3. Phospholipase C (PLC): PLC hydrolyzes the phosphodiester bond in the headgroup of a glycerophospholipid, releasing diacylglycerol (DAG) and a soluble head group, such as inositol trisphosphate (IP3). DAG acts as a secondary messenger in intracellular signaling pathways, while IP3 mediates the release of calcium ions from intracellular stores.
4. Phospholipase D (PLD): PLD cleaves the phosphoester bond between the headgroup and the glycerol moiety of a glycerophospholipid, releasing phosphatidic acid (PA) and a free head group. PA is an important signaling molecule involved in various cellular processes, including membrane trafficking, cytoskeletal reorganization, and cell survival.

Phospholipases have diverse roles in normal physiology and pathophysiological conditions, such as inflammation, immunity, and neurotransmission. Dysregulation of phospholipase activity can contribute to the development of various diseases, including cancer, cardiovascular disease, and neurological disorders.

Phospholipase C beta (PLCβ) is an enzyme that plays a crucial role in intracellular signaling transduction pathways. It is a subtype of Phospholipase C, which is responsible for cleaving phospholipids into secondary messengers, thereby mediating various cellular responses.

PLCβ is activated by G protein-coupled receptors (GPCRs) and can be found in various tissues throughout the body. Once activated, PLCβ hydrolyzes a specific phospholipid, PIP2 (Phosphatidylinositol 4,5-bisphosphate), into two secondary messengers: IP3 (Inositol 1,4,5-trisphosphate) and DAG (Diacylglycerol). These second messengers then trigger a series of downstream events, such as calcium mobilization and protein kinase C activation, which ultimately lead to changes in cell functions, including gene expression, cell growth, differentiation, and secretion.

There are four isoforms of PLCβ (PLCβ1, PLCβ2, PLCβ3, and PLCβ4) that differ in their tissue distribution, regulation, and substrate specificity. Mutations or dysregulation of PLCβ have been implicated in several diseases, including cancer, cardiovascular disease, and neurological disorders.

Phospholipase A2 (PLA2) is a type of enzyme that catalyzes the hydrolysis of the sn-2 ester bond in glycerophospholipids, releasing free fatty acids, such as arachidonic acid, and lysophospholipids. These products are important precursors for the biosynthesis of various signaling molecules, including eicosanoids, platelet-activating factor (PAF), and lipoxins, which play crucial roles in inflammation, immunity, and other cellular processes.

Phospholipases A2 are classified into several groups based on their structure, mechanism of action, and cellular localization. The secreted PLA2s (sPLA2s) are found in extracellular fluids and are characterized by a low molecular weight, while the calcium-dependent cytosolic PLA2s (cPLA2s) are larger proteins that reside within cells.

Abnormal regulation or activity of Phospholipase A2 has been implicated in various pathological conditions, such as inflammation, neurodegenerative diseases, and cancer. Therefore, understanding the biology and function of these enzymes is essential for developing novel therapeutic strategies to target these disorders.

Phospholipase C gamma (PLCγ) is an enzyme that plays a crucial role in intracellular signaling transduction pathways, particularly in the context of growth factor receptor-mediated signals and immune cell activation. It is a member of the phospholipase C family, which hydrolyzes phospholipids into secondary messengers to mediate various cellular responses.

PLCγ has two isoforms, PLCγ1 and PLCγ2, encoded by separate genes. These isoforms share structural similarities but have distinct expression patterns and functions. PLCγ1 is widely expressed in various tissues, while PLCγ2 is primarily found in hematopoietic cells.

PLCγ is activated through tyrosine phosphorylation by receptor tyrosine kinases (RTKs) or non-receptor tyrosine kinases such as Src and Syk family kinases. Once activated, PLCγ hydrolyzes the membrane phospholipid, phosphatidylinositol 4,5-bisphosphate (PIP2), into two secondary messengers: inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 stimulates the release of calcium ions from intracellular stores, while DAG activates protein kinase C (PKC), leading to a cascade of downstream signaling events that regulate cell proliferation, differentiation, survival, and migration.

In summary, Phospholipase C gamma (PLCγ) is an enzyme involved in intracellular signaling pathways by generating secondary messengers IP3 and DAG upon activation through tyrosine phosphorylation, ultimately regulating various cellular responses.

Phospholipases A are a group of enzymes that hydrolyze phospholipids into fatty acids and lysophospholipids by cleaving the ester bond at the sn-1 or sn-2 position of the glycerol backbone. There are three main types of Phospholipases A:

* Phospholipase A1 (PLA1): This enzyme specifically hydrolyzes the ester bond at the sn-1 position, releasing a free fatty acid and a lysophospholipid.
* Phospholipase A2 (PLA2): This enzyme specifically hydrolyzes the ester bond at the sn-2 position, releasing a free fatty acid (often arachidonic acid, which is a precursor for eicosanoids) and a lysophospholipid.
* Phospholipase A/B (PLA/B): This enzyme has both PLA1 and PLA2 activity and can hydrolyze the ester bond at either the sn-1 or sn-2 position.

Phospholipases A play important roles in various biological processes, including cell signaling, membrane remodeling, and host defense. They are also involved in several diseases, such as atherosclerosis, neurodegenerative disorders, and cancer.

Phosphatidylinositol Diacylglycerol-Lyase is an enzyme that plays a crucial role in the breakdown and metabolism of certain lipids known as phosphoinositides. These are important components of cell membranes and are involved in various cellular processes such as signal transduction.

The systematic name for this enzyme is 1-phosphatidyl-1D-myo-inositol-3,4-bisphosphate D-3-phosphoinositide phospholipase C. Its function is to cleave 1,2-diacylglycerol and inositol 1,3,4,5-tetrakisphosphate from 1-phosphatidyl-1D-myo-inositol-3,4-bisphosphate. This reaction is a key step in the phosphoinositide signaling pathway, which is involved in regulating various cellular functions such as cell growth, differentiation, and metabolism.

Defects in this enzyme have been associated with certain diseases, including neurological disorders and cancer. Therefore, understanding its function and regulation is an important area of research in biology and medicine.

An encyclopedia is a comprehensive reference work containing articles on various topics, usually arranged in alphabetical order. In the context of medicine, a medical encyclopedia is a collection of articles that provide information about a wide range of medical topics, including diseases and conditions, treatments, tests, procedures, and anatomy and physiology. Medical encyclopedias may be published in print or electronic formats and are often used as a starting point for researching medical topics. They can provide reliable and accurate information on medical subjects, making them useful resources for healthcare professionals, students, and patients alike. Some well-known examples of medical encyclopedias include the Merck Manual and the Stedman's Medical Dictionary.

Diacylglycerol kinase (DGK) is an enzyme that plays a role in regulating cell signaling pathways. It catalyzes the conversion of diacylglycerol (DAG), a lipid second messenger, to phosphatidic acid (PA). This reaction helps to terminate DAG-mediated signals and initiate PA-mediated signals, which are involved in various cellular processes such as proliferation, differentiation, and survival. There are several isoforms of DGK that differ in their regulation, subcellular localization, and substrate specificity. Inhibition or genetic deletion of DGK has been shown to affect a variety of physiological and pathological processes, including inflammation, immunity, cancer, and neurological disorders.

Diacylglycerols (also known as diglycerides) are a type of glyceride, which is a compound that consists of glycerol and one or more fatty acids. Diacylglycerols contain two fatty acid chains bonded to a glycerol molecule through ester linkages. They are important intermediates in the metabolism of lipids and can be found in many types of food, including vegetable oils and dairy products. In the body, diacylglycerols can serve as a source of energy and can also play roles in cell signaling processes.

Protein Kinase C (PKC) is a family of serine-threonine kinases that play crucial roles in various cellular signaling pathways. These enzymes are activated by second messengers such as diacylglycerol (DAG) and calcium ions (Ca2+), which result from the activation of cell surface receptors like G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs).

Once activated, PKC proteins phosphorylate downstream target proteins, thereby modulating their activities. This regulation is involved in numerous cellular processes, including cell growth, differentiation, apoptosis, and membrane trafficking. There are at least 10 isoforms of PKC, classified into three subfamilies based on their second messenger requirements and structural features: conventional (cPKC; α, βI, βII, and γ), novel (nPKC; δ, ε, η, and θ), and atypical (aPKC; ζ and ι/λ). Dysregulation of PKC signaling has been implicated in several diseases, such as cancer, diabetes, and neurological disorders.

Phospholipids are a major class of lipids that consist of a hydrophilic (water-attracting) head and two hydrophobic (water-repelling) tails. The head is composed of a phosphate group, which is often bound to an organic molecule such as choline, ethanolamine, serine or inositol. The tails are made up of two fatty acid chains.

Phospholipids are a key component of cell membranes and play a crucial role in maintaining the structural integrity and function of the cell. They form a lipid bilayer, with the hydrophilic heads facing outwards and the hydrophobic tails facing inwards, creating a barrier that separates the interior of the cell from the outside environment.

Phospholipids are also involved in various cellular processes such as signal transduction, intracellular trafficking, and protein function regulation. Additionally, they serve as emulsifiers in the digestive system, helping to break down fats in the diet.

Second messenger systems are a type of intracellular signaling pathway that allows cells to respond to external signals, such as hormones and neurotransmitters. When an extracellular signal binds to a specific receptor on the cell membrane, it activates a G-protein or an enzyme associated with the receptor. This activation leads to the production of a second messenger molecule inside the cell, which then propagates the signal and triggers various intracellular responses.

Examples of second messengers include cyclic adenosine monophosphate (cAMP), cyclic guanosine monophosphate (cGMP), inositol trisphosphate (IP3), diacylglycerol (DAG), and calcium ions (Ca2+). These second messengers activate or inhibit various downstream effectors, such as protein kinases, ion channels, and gene transcription factors, leading to changes in cellular functions, such as metabolism, gene expression, cell growth, differentiation, and apoptosis.

Second messenger systems play crucial roles in many physiological processes, including sensory perception, neurotransmission, hormonal regulation, immune response, and development. Dysregulation of these systems can contribute to various diseases, such as cancer, diabetes, cardiovascular disease, and neurological disorders.